83 related articles for article (PubMed ID: 16717445)
1. Classification of DNA methylation patterns in tumor cell genomes using a CpG island microarray.
Adrien LR; Schlecht NF; Kawachi N; Smith RV; Brandwein-Gensler M; Massimi A; Chen S; Prystowsky MB; Childs G; Belbin TJ
Cytogenet Genome Res; 2006; 114(1):16-23. PubMed ID: 16717445
[TBL] [Abstract][Full Text] [Related]
2. Differential methylation hybridization: profiling DNA methylation with a high-density CpG island microarray.
Yan PS; Potter D; Deatherage DE; Huang TH; Lin S
Methods Mol Biol; 2009; 507():89-106. PubMed ID: 18987809
[TBL] [Abstract][Full Text] [Related]
3. LHX6 is a sensitive methylation marker in head and neck carcinomas.
Estécio MR; Youssef EM; Rahal P; Fukuyama EE; Góis-Filho JF; Maniglia JV; Goloni-Bertollo EM; Issa JP; Tajara EH
Oncogene; 2006 Aug; 25(36):5018-26. PubMed ID: 16732332
[TBL] [Abstract][Full Text] [Related]
4. CpG island arrays: an application toward deciphering epigenetic signatures of breast cancer.
Yan PS; Perry MR; Laux DE; Asare AL; Caldwell CW; Huang TH
Clin Cancer Res; 2000 Apr; 6(4):1432-8. PubMed ID: 10778974
[TBL] [Abstract][Full Text] [Related]
5. Methylation microarray analysis of late-stage ovarian carcinomas distinguishes progression-free survival in patients and identifies candidate epigenetic markers.
Wei SH; Chen CM; Strathdee G; Harnsomburana J; Shyu CR; Rahmatpanah F; Shi H; Ng SW; Yan PS; Nephew KP; Brown R; Huang TH
Clin Cancer Res; 2002 Jul; 8(7):2246-52. PubMed ID: 12114427
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide profiling of promoter methylation in human.
Hatada I; Fukasawa M; Kimura M; Morita S; Yamada K; Yoshikawa T; Yamanaka S; Endo C; Sakurada A; Sato M; Kondo T; Horii A; Ushijima T; Sasaki H
Oncogene; 2006 May; 25(21):3059-64. PubMed ID: 16407832
[TBL] [Abstract][Full Text] [Related]
7. A sensitive new method for rapid detection of abnormal methylation patterns in global DNA and within CpG islands.
Pogribny I; Yi P; James SJ
Biochem Biophys Res Commun; 1999 Sep; 262(3):624-8. PubMed ID: 10471374
[TBL] [Abstract][Full Text] [Related]
8. MIRA-assisted microarray analysis, a new technology for the determination of DNA methylation patterns, identifies frequent methylation of homeodomain-containing genes in lung cancer cells.
Rauch T; Li H; Wu X; Pfeifer GP
Cancer Res; 2006 Aug; 66(16):7939-47. PubMed ID: 16912168
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation analysis using CpG microarrays is impaired in benzopyrene exposed cells.
Sadikovic B; Andrews J; Rodenhiser DI
Toxicol Appl Pharmacol; 2007 Dec; 225(3):300-9. PubMed ID: 17904174
[TBL] [Abstract][Full Text] [Related]
10. Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma.
Nayak CS; Carvalho AL; Jeronimo C; Henrique R; Kim MM; Hoque MO; Chang S; Jiang WW; Koch W; Westra W; Sidransky D; Califano J
Laryngoscope; 2007 Aug; 117(8):1376-80. PubMed ID: 17592394
[TBL] [Abstract][Full Text] [Related]
11. Dissecting complex epigenetic alterations in breast cancer using CpG island microarrays.
Yan PS; Chen CM; Shi H; Rahmatpanah F; Wei SH; Caldwell CW; Huang TH
Cancer Res; 2001 Dec; 61(23):8375-80. PubMed ID: 11731411
[TBL] [Abstract][Full Text] [Related]
12. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
[TBL] [Abstract][Full Text] [Related]
13. [Screening for differential methylation status by CpG island microarray in the hepatocellular carcinoma cell lines].
Zheng D; Liu BB; Liu YK; Kang XN; Sun L; Guo K; Sun RX; Chen J; Zhao Y
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):891-6. PubMed ID: 19173987
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.
Gebhard C; Schwarzfischer L; Pham TH; Schilling E; Klug M; Andreesen R; Rehli M
Cancer Res; 2006 Jun; 66(12):6118-28. PubMed ID: 16778185
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation and ovarian cancer. I. Analysis of CpG island hypermethylation in human ovarian cancer using differential methylation hybridization.
Ahluwalia A; Yan P; Hurteau JA; Bigsby RM; Jung SH; Huang TH; Nephew KP
Gynecol Oncol; 2001 Aug; 82(2):261-8. PubMed ID: 11531277
[TBL] [Abstract][Full Text] [Related]
16. Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma.
Hsiung DT; Marsit CJ; Houseman EA; Eddy K; Furniss CS; McClean MD; Kelsey KT
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):108-14. PubMed ID: 17220338
[TBL] [Abstract][Full Text] [Related]
17. Differential methylation status of tumor-associated genes in head and neck squamous carcinoma: incidence and potential implications.
Maruya S; Issa JP; Weber RS; Rosenthal DI; Haviland JC; Lotan R; El-Naggar AK
Clin Cancer Res; 2004 Jun; 10(11):3825-30. PubMed ID: 15173091
[TBL] [Abstract][Full Text] [Related]
18. Microarray-based DNA methylation profiling: technology and applications.
Schumacher A; Kapranov P; Kaminsky Z; Flanagan J; Assadzadeh A; Yau P; Virtanen C; Winegarden N; Cheng J; Gingeras T; Petronis A
Nucleic Acids Res; 2006; 34(2):528-42. PubMed ID: 16428248
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma.
Carvalho AL; Jeronimo C; Kim MM; Henrique R; Zhang Z; Hoque MO; Chang S; Brait M; Nayak CS; Jiang WW; Claybourne Q; Tokumaru Y; Lee J; Goldenberg D; Garrett-Mayer E; Goodman S; Moon CS; Koch W; Westra WH; Sidransky D; Califano JA
Clin Cancer Res; 2008 Jan; 14(1):97-107. PubMed ID: 18172258
[TBL] [Abstract][Full Text] [Related]
20. Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma.
Carvalho AL; Chuang A; Jiang WW; Lee J; Begum S; Poeta L; Zhao M; Jerónimo C; Henrique R; Nayak CS; Park HL; Brait MR; Liu C; Zhou S; Koch W; Fazio VM; Ratovitski E; Trink B; Westra W; Sidransky D; Moon CS; Califano JA
Cancer Res; 2006 Oct; 66(19):9401-7. PubMed ID: 17018594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]